lly

Sector Update: Healthcare Shares Mixed Pre-Market; Durata up 2.4% on Buy Rating at MLV

Top Healthcare stocks:

JNJ: 0.04%

PFE: -0.27%

ABT: +0.03%

MRK: flat

AMGN: -0.05%

Healthcare shares were generally mixed in pre-market trade on Thursday.

In healthcare stocks news, coverage of pharmaceutical company Durata Therapeutics Inc. ( DRTX ) shares were up 2.4% after it was been initiated by analysts at MLV & Co. with a buy rating and a price target of $21 a share.

The price target represents a potential upside of 31% from the stock' current trading price.

In the pre-market session, shares of DRTX are level at $16.01, amid a 52-week spread of $6.70 - $17.20.

And, Agile Therapeutics ( AGRX ) said it has priced its initial public offering of approximately 9.2 million shares at $6.00 per share.

The pharmaceutical company that specializes in women's health said it has granted underwriters a 30-day option to acquire an additional 1.38 million shares at the IPO price to cover any over-allotments.

It will start trading on the Nasdaq Global Market Friday under the ticker AGRX.

Finally, Eli Lilly ( LLY ) and Boehringer Ingelheim Pharmaceuticals said the European Commission has approved its Jardiance tablets for use in adults with type 2 diabetes.

The tablets, a sodium glucose co-transporter 2 inhibitor, for the treatment of type 2 diabetes mellitus to improve glycemic control, has been approved for once daily use when diet and exercise alone do not provide adequate glycemic control.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.